XML 381 R77.htm IDEA: XBRL DOCUMENT
v3.25.1

SHARE CAPITAL (Details Narrative) |  |  |  |  |  |  |  |  | 12 Months Ended |  |  |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 03, 2024 USD ($) $ / shares shares | Dec. 03, 2024 CAD ($) $ / shares | Sep. 25, 2024 USD ($) $ / shares shares | Sep. 25, 2024 CAD ($) $ / shares | Jul. 19, 2024 USD ($) $ / shares shares | Jul. 19, 2024 CAD ($) | May 10, 2024 USD ($) $ / shares shares | May 10, 2024 CAD ($) | May 03, 2024 USD ($) $ / shares shares | May 03, 2024 CAD ($) | Jan. 24, 2024 USD ($) $ / shares shares | Jan. 24, 2024 CAD ($) | Dec. 04, 2023 USD ($) $ / shares shares | Dec. 04, 2023 USD ($) $ / shares shares | Dec. 02, 2022 USD ($) $ / shares shares | Dec. 02, 2022 CAD ($) | Dec. 31, 2024 USD ($) $ / shares shares | Dec. 31, 2023 USD ($) $ / shares | Dec. 31, 2022 USD ($) $ / shares shares | Dec. 03, 2024 $ / shares | Sep. 25, 2024 $ / shares | Jul. 19, 2024 $ / shares | May 10, 2024 $ / shares | May 03, 2024 $ / shares | Jan. 24, 2024 $ / shares | Dec. 31, 2022 $ / shares | Dec. 02, 2022 $ / shares
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued to settle accounts payable, value |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 40,029 |  |  |  |  |  |  |  |
Shares issued to settle accounts payable, shares | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,422 |  |  |  |  |  |  |  |
Price per share | (per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 7.38 |  |  |  |  |  |  | $ 9.38 |
Number of shares issued | shares | 5,555,556 |  | 4,000,000 |  | 3,333,334 |  |  |  |  |  |  |  | 1,786,000 | 1,786,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant expected life |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |
Gross proceeds, shares | $ 25,000,002 | $ 35,000,003 | $ 15,000,000 | $ 20,400,000 | $ 10,000,000 | $ 13,700,003 |  |  |  |  |  |  | $ 1,607,400 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of expected common shares | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Average share price | (per share) | $ 4.50 | $ 6.29 | $ 3.75 | $ 5.10 |  |  |  |  |  |  |  |  |  |  |  |  | $ 2.12 | $ 4.11 | $ 3.32 |  |  |  |  |  |  |  |
At the market [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,449,723 |  |  |  |  |  |  |  |  |  |
Gross proceeds from private offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 9,362,235 |  |  |  |  |  |  |  |  |  |
Average share price | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.72 |  |  |  |  |  |  |  |  |  |
Commissions paid to agent percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.00% |  |  |  |  |  |  |  |  |  |
Commissions paid to agent |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 280,867 |  |  |  |  |  |  |  |  |  |
Director, management and employees [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds, shares |  |  |  |  |  |  |  |  |  |  | $ 415,272 | $ 560,617 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  |  |  | 459,522 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private placement offering [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share | (per share) | $ 6.00 |  | $ 5.00 |  | $ 4.00 |  |  |  |  |  | $ 1.12 |  |  |  |  |  |  |  |  |  | $ 6.78 | $ 5.45 | $ 4.26 | $ 4.26 | $ 1.52 |  |
Number of shares issued | shares | 5,555,556 |  | 4,000,000 |  | 3,333,334 |  | 3,448,275 |  | 3,258,390 |  | 5,098,088 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issuance costs | $ 597,318 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expected dividend as percentage, warrants | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds, shares | $ 25,000,002 | $ 35,000,003 | $ 15,000,000 | $ 20,400,000 | $ 10,000,000 | $ 13,700,003 | $ 7,299,270 | $ 10,000,000 | $ 7,299,270 | $ 10,000,000 | $ 4,613,312 | $ 6,219,667 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement | (per share) | $ 4.50 |  | $ 3.75 |  | $ 3.00 |  | $ 2.12 |  | $ 2.24 |  | $ 0.90 |  |  |  |  |  |  |  |  | $ 6.29 | $ 5.10 | $ 4.09 | $ 2.90 | $ 3.069 | $ 1.22 |  |
Description of expected common shares | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Underwritten public offering [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  | 1,786,000 | 1,786,000 |  |  |  |  |  |  |  |  |  |  |  |  |
exercise price | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.12 | $ 1.12 |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds, shares |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,607,400 |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.90 | $ 0.90 |  |  |  |  |  |  |  |  |  |  |  |  |
Additional purchase | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 240,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Underwritten public offering [member] | Warrants [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additional purchase | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 186,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock [member] | Private placement offering [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share | (per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2.78 |  |  |  |  |  |  |  |  |  |  |  | $ 3.81
Number of shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,126,635 |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from private offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,184,332 | $ 4,292,479 |  |  |  |  |  |  |  |  |  |  |
exercise price | (per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3.61 |  |  |  |  |  |  |  |  |  |  |  | $ 4.95
Cash commission |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 42,090 | $ 57,897 |  |  |  |  |  |  |  |  |  |  |
Share issuance costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 205,802 |  |  |  |  |  |  |  |  |  |  |  |
Expected dividend as percentage, warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% | 0.00% |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate, warrants | 2.91% | 2.91% | 2.79% | 2.79% | 3.35% | 3.35% | 3.67% | 3.67% | 3.67% | 3.67% | 3.50% | 3.50% |  |  | 3.48% | 3.48% |  |  |  |  |  |  |  |  |  |  |
Expected volatility, warrants | 88.05% | 88.05% | 87.63% | 87.63% | 85.93% | 85.93% | 83.00% | 83.00% | 83.00% | 83.00% | 78.35% | 78.35% |  |  | 69.93% | 69.93% |  |  |  |  |  |  |  |  |  |  |
Warrant expected life | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years |  |  | 3 years | 3 years |  |  |  |  |  |  |  |  |  |  |
Fair value of warrants | $ 8,127,620 |  | $ 4,842,347 |  | $ 6,430,362 |  | $ 4,435,105 |  | $ 4,513,393 |  | $ 2,815,861 |  |  |  | $ 656,734 |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 227,673 |  |  |  |  |  |  |  |  |
Common stock [member] | Private placement offering [member] | Key management personnel of entity or parent [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10,000 |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from private offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 27,800 | $ 38,100 |  |  |  |  |  |  |  |  |  |  |
Common stock [member] | Equity distribution agreement [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from private offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 983,194 |  |  |  |  |  |  |  |  |
Finance costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 291,226 |  |  |  |  |  |  |  |  |
Common stock [member] | Equity distribution agreement [member] | At the market [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from private offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 29,486 |  |  |  |  |  |  |  |  |
Gross proceeds |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 30,000,000 |  |  |  |  |  |  |  |  |
Commision paid percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.00% |  |  |  |  |  |  |  |  |
Common stock [member] | Underwritten public offering [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds from private offering |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 112,518 |  |  |  |  |  |  |  |  |  |  |  |  |
Expected dividend as percentage, warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate, warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.54% |  |  |  |  |  |  |  |  |  |  |  |  |
Expected volatility, warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | 75.66% |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant expected life |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrants |  |  |  |  |  |  |  |  |  |  |  |  | $ 954,537 | $ 954,537 |  |  |  |  |  |  |  |  |  |  |  |  |
Commision paid percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Finance costs |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 145,089 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant reserve [member] | Underwritten public offering [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  |  |  |  |  | 1,600,000 | 1,600,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares | 2,777,778 |  | 2,000,000 |  | 3,333,334 |  |  |  |  |  |  |  | 1,786,000 | 1,786,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants [member] | Private placement offering [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares purchased | shares | 2,777,778 |  | 2,000,000 |  | 3,333,334 |  | 3,448,275 |  | 3,258,390 |  | 5,098,088 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants [member] | Underwritten public offering [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares purchased | shares |  |  |  |  |  |  |  |  |  |  |  |  | 1,600,000 | 1,600,000 |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Commision paid percentage. + References No definition available. + Details
Name: | POET_CommisionPaidPercentage
Namespace Prefix: | POET_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Commissions payable. + References No definition available. + Details
Name: | POET_CommissionsPayable
Namespace Prefix: | POET_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Commissions payable percentage. + References No definition available. + Details
Name: | POET_CommissionsPayablePercentage
Namespace Prefix: | POET_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of expected common shares. + References No definition available. + Details
Name: | POET_DescriptionOfExpectedCommonShares
Namespace Prefix: | POET_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of an expected dividend used to calculate the fair value of warrants. + References No definition available. + Details
Name: | POET_ExpectedDividendAsPercentageWarrants
Namespace Prefix: | POET_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The expected volatility of the share price used to calculate the fair value of warrants. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in warrants pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References No definition available. + Details
Name: | POET_ExpectedVolatilityWarrants
Namespace Prefix: | POET_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of warrants. + References No definition available. + Details
Name: | POET_FairValueOfWarrants
Namespace Prefix: | POET_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Gross proceeds. + References No definition available. + Details
Name: | POET_GrossProceeds
Namespace Prefix: | POET_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Gross proceeds from private offering. + References No definition available. + Details
Name: | POET_GrossProceedsFromPrivateOffering
Namespace Prefix: | POET_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | POET_IfrsStatementLineItems
Namespace Prefix: | POET_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issued units. + References No definition available. + Details
Name: | POET_NumberOfSharesIssuedUnits
Namespace Prefix: | POET_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares purchased. + References No definition available. + Details
Name: | POET_NumberOfSharesPurchased
Namespace Prefix: | POET_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for warrants is expressed, with a remaining term equal to the expected term of the warrants being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). + References No definition available. + Details
Name: | POET_RiskFreeInterestRateWarrants
Namespace Prefix: | POET_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share issue related share. + References No definition available. + Details
Name: | POET_ShareIssueRelatedShare
Namespace Prefix: | POET_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Shares issued to settle payables. + References No definition available. + Details
Name: | POET_SharesIssuedToSettlePayables
Namespace Prefix: | POET_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Shares issued to settle payables, shares. + References No definition available. + Details
Name: | POET_SharesIssuedToSettlePayablesShares
Namespace Prefix: | POET_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrant exercise price per share. + References No definition available. + Details
Name: | POET_WarrantExercisePricePerShare
Namespace Prefix: | POET_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Warrant expected life. + References No definition available. + Details
Name: | POET_WarrantExpectedLife
Namespace Prefix: | POET_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of expense relating to fees and commissions. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_FeeAndCommissionExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of costs associated with financing activities of the entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 82 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_FinanceCosts
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfSharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The nominal value per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 79 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_79_a_iii&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ParValuePerShare
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from issuing shares. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 17 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_17_a&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ProceedsFromIssuingShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of cost related to the issuance of shares. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ShareIssueRelatedCost
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The weighted average exercise price of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average share price. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_c&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageSharePrice2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ClassesOfAssetsAxis=POET_AtTheMarketMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=POET_DirectorManagementAndEmployeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfContractsAxis=POET_PrivatePlacementOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfContractsAxis=POET_UnderwrittenPublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=POET_CommonStocksMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfContractsAxis=POET_EquityDistributionAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=ifrs-full_WarrantReserveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=ifrs-full_WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |